Hypericum perforatum L (St John's wort) preferentially increases extracellular dopamine levels in the rat prefrontal cortex
- 1 June 2004
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 142 (3), 414-418
- https://doi.org/10.1038/sj.bjp.0705822
Abstract
The effects of hydro-alcoholic extracts of Hypericum perforatum L on extracellular serotonin (5-HT), noradrenaline (NA) and dopamine (DA) levels and the acidic metabolites (3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and 5-hydroxy-3-indoleacetic acid (5-HIAA)) were examined by in vivo microdialysis in the prefrontal cortex of awake rats. Thus, a single dose (60 mg kg(-1) i.p. or 300 mg kg(-1) p.o.) of H. perforatum increased DA concentrations to 165 and 140% of control values, respectively, and increased locomotor activity in nonhabituated rats. DOPAC and HVA levels were markedly reduced. 5-HT concentrations were elevated only moderately, while the NA levels were not affected by any treatment. The whole-tissue analysis revealed that hypericum increased, whereas the monoamine oxidase (MAO) A/B inhibitor phenelzine decreased DA and 5-HT turnover. The present data indicate that the mechanism of action of hypericum extract in vivo is more complex than the inhibition of monoamine reuptake or metabolism observed in vitro. The finding of preferential enhancement of DA transmission is in agreement with human studies measuring DA-mediated neuroendocrine responses.This publication has 23 references indexed in Scilit:
- Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamineJournal of Chromatography B, 2004
- Mechanism of Action of St John???s Wort in DepressionCNS Drugs, 2003
- Efficacy of St. John’s Wort Extract WS 5570 in Major Depression: A Double-Blind, Placebo-Controlled TrialAmerican Journal of Psychiatry, 2002
- Effect of Hypericum perforatum (St John's Wort) in Major Depressive DisorderJAMA, 2002
- Effect of Acute Administration of Hypericum Perforatum-CO2Extract on Dopamine and Serotonin Release in the Rat Central Nervous SystemPharmacopsychiatry, 2000
- Hyperforin Represents the Neurotransmitter Reuptake Inhibiting Constituent of Hypericum ExtractPharmacopsychiatry, 1998
- Effects of Hypericum Extract (LI 160) in Biochemical Models of Antidepressant ActivityPharmacopsychiatry, 1997
- Inhibition of MAO by Fractions and Constituents of Hypericum ExtractJournal of Geriatric Psychiatry and Neurology, 1994
- Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic TerminalsJournal of Neurochemistry, 1990
- Inhibition of Monoamine Oxidase by HypercinPlanta Medica, 1984